Hal E. Broxmeyer, PhD, is Distinguished Professor, Chairman and Mary Margaret Walther Professor of Microbiology/Immunology, and Professor of Medicine at the Indiana University School of Medicine. He also serves as the Scientific Director of the Walther Oncology Center.

Dr. Broxmeyer earned his doctorate from New York University in 1973, completed his postdoctorate at Queens University in Kingston, Ontario, Canada, and trained as an associate researcher at Memorial Sloan Kettering Cancer Center in New York.

Prior to his position as President, Dr. Broxmeyer served as President-Elect, on the Executive Committee as a Councillor from 2002-2005, on ASH’s Committee on Investment and Audit, and on the Publications Committee (now known as the Journals Committee). In addition, Dr. Broxmeyer was chosen for ASH’s esteemed E. Donnall Thomas Lecture and Prize in 2007.

Dr. Broxmeyer has published more than 630 papers and currently sits on the editorial board of 10 scientific journals. In the past, he has served on the Blood Editorial Board and participated in the subcommittee that shepherded Blood to self-publication in 2000.

Dr. Broxmeyer’s major areas of interest include stem/progenitor cell regulation, cytokines and chemokines, and clinical transplantation.

back to top